Literature DB >> 26645394

Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.

Berit Jordan1, Susanne Schilling2, Stephan Zierz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26645394     DOI： 10.1007/s00415-015-7982-2

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.

Authors:  E Saka; M A Topcuoglu; B Akkaya; A Galati; M Z Onal; A Vincent
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.

Authors:  A Rostedt Punga; K Ahlqvist; E Bartoccioni; F Scuderi; M Marino; A Suomalainen; H Kalimo; E V Stålberg
Journal:  Clin Neurophysiol       Date:  2006-06-05       Impact factor: 3.708

3.  Double-seropositive myasthenia gravis.

Authors:  Vasiliki Zouvelou; Stavroula Kyriazi; Michael Rentzos; Maria Belimezi; Maria-Angeliki Micheli; Socrates J Tzartos; Eleftherios Stamboulis
Journal:  Muscle Nerve       Date:  2013-01-16       Impact factor: 3.217

4.  Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.

Authors:  Jeffrey T Guptill; Donald B Sanders; Amelia Evoli
Journal:  Muscle Nerve       Date:  2011-07       Impact factor: 3.217

5.  AChR-myasthenia gravis switching to double-seropositive several years after the onset.

Authors:  Vasiliki Zouvelou; Paraskevi Zisimopoulou; Erasmia Psimenou; Eirini Matsigkou; Eleftherios Stamboulis; Socrates J Tzartos
Journal:  J Neuroimmunol       Date:  2013-12-22       Impact factor: 3.478

6.  Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.

Authors:  Konstantinos Poulas; Euphrosyni Koutsouraki; Gregory Kordas; Anna Kokla; Socrates J Tzartos
Journal:  J Neuroimmunol       Date:  2012-06-09       Impact factor: 3.478

Review 7.  Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.

Authors:  Amelia Evoli; Luca Padua
Journal:  Autoimmun Rev       Date:  2013-03-25       Impact factor: 9.754

8.  [A case of thymoma-associated myasthenia gravis with anti-MuSK antibodies].

Authors:  Ai Ito; Ryogen Sasaki; Yuichiro Ii; Shigeho Nakayama; Masakatsu Motomura; Hidekazu Tomimoto
Journal:  Rinsho Shinkeigaku       Date:  2013

9.  Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.

Authors:  Jordi Díaz-Manera; Ricard Rojas-García; Eduard Gallardo; Cándido Juárez; Alejandro Martínez-Domeño; Sergi Martínez-Ramírez; Josep Dalmau; Rafael Blesa; Isabel Illa
Journal:  Nat Clin Pract Neurol       Date:  2007-07

10.  Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.

Authors:  Anna Kostera-Pruszczyk; Hubert Kwiecinski
Journal:  J Neurol       Date:  2009-06-23       Impact factor: 4.849
  10 in total
  2 in total

Review 1.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

2.  Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imaging.

Authors:  Berit Jordan; Juliane Kellner; Karin Jordan; Manfred Bähre; Curd Behrmann; Stephan Zierz
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.